Knee Replacement Market Size, Share, Growth, and Industry Analysis, By Type (Primary Knee Replacement,Partial Knee Replacement,Revision Knee Replacement), By Application (ASCs,Hospitals), Regional Insights and Forecast to 2035

Knee Replacement Market Overview

Global Knee Replacement Market size is estimated at USD 937384.93 million in 2026, set to expand to USD 1261267.01 million by 2035, growing at a CAGR of 3.0%.

The Knee Replacement market recorded more than 3.9 million surgical procedures globally during 2024, supported by rising osteoarthritis prevalence affecting nearly 528 million people worldwide. Total knee replacement procedures represented 81% of all knee reconstruction surgeries, while robotic-assisted systems accounted for 19% of procedures in advanced healthcare centers. Cemented implants maintained 72% usage across hospitals due to higher fixation reliability. Titanium-based implants represented 46% of implanted materials, while cobalt-chromium alloys accounted for 39%. Patients aged above 60 years contributed 68% of procedure demand. Digital orthopedic planning systems were utilized in 41% of surgical centers, improving implant positioning accuracy by 27% compared with conventional approaches.

The United States accounted for nearly 1.2 million knee replacement surgeries during 2024, with primary knee replacement procedures contributing 88% of total surgeries. More than 54% of orthopedic hospitals in the country adopted robotic-assisted knee replacement systems. The obesity rate among adults reached 40%, significantly increasing degenerative joint disease incidence. Around 790,000 total knee arthroplasties were performed annually among patients aged above 65 years. Outpatient knee replacement surgeries represented 36% of total procedures in the USA due to faster recovery protocols. Medicare-supported procedures covered approximately 63% of surgeries, while advanced personalized implants were utilized in 29% of complex orthopedic cases.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: Rising osteoarthritis prevalence contributed to 61% of total knee replacement demand, while obesity-related joint degeneration accounted for 44% of surgical cases and aging populations above 65 years represented 68% of procedure volumes globally.
• Major Market Restraint: Approximately 31% of patients delayed surgery due to high implant costs, while 22% experienced postoperative complications and 17% of orthopedic centers reported shortages of trained robotic surgery specialists.
• Emerging Trends: Robotic-assisted knee replacement adoption increased to 19% globally, customized implant usage reached 27%, minimally invasive procedures represented 38%, and outpatient surgical procedures accounted for 36% of total operations.
• Regional Leadership: North America maintained 42% market share due to high procedure volumes, Europe accounted for 29%, Asia-Pacific represented 21%, and Middle East & Africa contributed 8% of total procedures.
• Competitive Landscape: The top five manufacturers controlled 67% of implant distribution, while robotic surgical technology penetration reached 24% among leading orthopedic companies and personalized implant manufacturing represented 18% of production.
• Market Segmentation: Primary knee replacement accounted for 74% of procedures, partial knee replacement represented 16%, revision procedures contributed 10%, hospitals handled 79% of surgeries, and ASCs represented 21% of treatment facilities.
• Recent Development: During 2024, robotic surgery installations increased by 23%, AI-assisted surgical planning adoption reached 17%, personalized 3D-printed implant usage rose to 14%, and smart implant monitoring systems expanded by 11%.

Knee Replacement Market Latest Trends

The Knee Replacement market is witnessing strong technological transformation due to increasing demand for precision orthopedic surgeries. Robotic-assisted surgery systems were utilized in more than 410,000 procedures globally during 2024, improving implant alignment accuracy by 32%. Artificial intelligence-assisted preoperative planning tools reduced surgical preparation time by 21% in high-volume orthopedic centers. Customized knee implants manufactured through 3D printing technologies accounted for 14% of total implant production, especially among patients requiring revision procedures.

Minimally invasive knee replacement techniques gained traction, representing 38% of all surgeries performed in developed healthcare systems. These techniques reduced hospitalization duration from 5 days to 2 days and lowered blood loss by nearly 29%. Outpatient knee replacement surgeries represented 36% of total procedures in the United States and 24% in Europe due to improved pain management technologies.

Knee Replacement Market Dynamics

DRIVER

"Rising demand for orthopedic surgeries due to osteoarthritis prevalence."

The increasing prevalence of osteoarthritis is the primary growth driver for the Knee Replacement market. More than 365 million individuals globally suffer from knee osteoarthritis, while approximately 10% of men and 18% of women above 60 years experience symptomatic knee degeneration. Aging populations are significantly contributing to procedure demand, with individuals aged above 65 years representing 68% of all surgeries performed globally. Obesity also remains a major factor, as overweight individuals have 4 times higher risk of knee joint deterioration. Robotic-assisted surgical technologies improved implant precision by 32%, increasing patient confidence and procedure acceptance rates. Hospital adoption of minimally invasive surgery techniques rose by 38%, reducing recovery periods and encouraging higher surgical volumes among elderly patients.

RESTRAINT

"High procedure and implant costs limiting accessibility."

The high cost associated with knee replacement surgeries continues to restrain market expansion across developing economies. Approximately 31% of eligible patients postpone surgery due to financial limitations, while advanced robotic-assisted procedures increase operational expenses by nearly 26%. Premium implants equipped with customized designs cost 35% more than conventional implants, limiting adoption among mid-income healthcare facilities. Postoperative complications such as infections occur in nearly 2% of procedures, increasing hospitalization costs significantly. Limited reimbursement coverage in several countries affects patient accessibility, particularly in regions where public healthcare spending remains below 6% of GDP. Training requirements for robotic surgery systems also create operational challenges, as only 24% of orthopedic surgeons globally possess certified robotic surgery expertise.

OPPORTUNITY

"Expansion of robotic-assisted and personalized knee replacement technologies."

The increasing adoption of robotic-assisted surgery systems creates substantial growth opportunities for implant manufacturers and healthcare providers. More than 54% of orthopedic hospitals in developed economies integrated robotic systems into surgical departments during 2024. Personalized knee implants manufactured through 3D printing technologies improved patient fit accuracy by 28%, reducing implant loosening rates significantly. Emerging economies are increasing orthopedic healthcare investments, with Asia-Pacific countries expanding orthopedic surgical centers by 17% annually. Smart implant monitoring systems capable of transmitting postoperative performance data are creating new digital healthcare opportunities. Ambulatory surgical centers are also gaining traction, handling 21% of total procedures globally due to lower operating costs and shorter patient recovery times.

CHALLENGE

"Rising revision surgery rates and skilled workforce shortages."

Revision knee replacement surgeries remain a major challenge for the orthopedic industry, accounting for approximately 10% of total procedures globally. Implant wear, infection, and loosening contribute to nearly 44% of revision cases. Revision surgeries require 37% longer operation times and higher implant complexity compared with primary procedures. The shortage of trained orthopedic surgeons is another significant challenge, particularly in developing economies where surgeon-to-patient ratios remain below 1 per 100,000 population. Robotic-assisted surgeries require specialized training programs lasting over 12 months, limiting rapid adoption. Supply chain disruptions also affected implant material availability during recent years, increasing delivery lead times by 16% for titanium-based components and surgical instrumentation.

Knee Replacement Market Segmentation

Download FREE Sample to learn more about this report.

By Type

Primary Knee Replacement: Primary knee replacement dominated the Knee Replacement market with nearly 74% market share during 2024. More than 2.8 million primary knee replacement procedures were performed globally due to rising osteoarthritis incidence among aging populations. Patients aged above 60 years represented 69% of total primary procedures. Cemented implants accounted for 71% of surgeries because of superior long-term fixation performance. Robotic-assisted primary surgeries increased by 24% during the last two years, improving alignment precision by 32%. Hospitals performing more than 500 orthopedic procedures annually reported postoperative complication rates below 2%. Minimally invasive techniques represented 41% of primary surgeries, reducing recovery periods to nearly 3 days compared with traditional procedures requiring 6 days of hospitalization.

Partial Knee Replacement: Partial knee replacement accounted for approximately 16% of the Knee Replacement market, mainly among patients with localized cartilage damage affecting a single knee compartment. More than 610,000 partial knee replacement surgeries were performed globally during 2024. Patients aged between 45 and 60 years represented 48% of these procedures due to earlier intervention preferences. Partial procedures reduced bone removal by 38% compared with total knee replacement surgeries. Recovery duration averaged 4 weeks, significantly shorter than total replacement procedures requiring 8 weeks. Robotic-assisted technologies supported 27% of partial procedures because of higher precision requirements. Mobile-bearing implants represented 22% of partial surgeries due to improved knee flexibility and patient mobility outcomes.

Revision Knee Replacement: Revision knee replacement represented nearly 10% of total procedures globally during 2024. Approximately 390,000 revision surgeries were conducted due to implant loosening, infection, instability, and wear-related complications. Infection-related failures accounted for 24% of revision procedures, while implant loosening contributed 33%. Revision surgeries required 37% longer operating time compared with primary replacements. Customized implants manufactured using 3D printing technologies were utilized in 19% of revision cases to improve fit accuracy. Patients undergoing revision procedures experienced hospitalization periods averaging 6 days, compared with 3 days for primary surgeries. Titanium revision implants accounted for 43% of procedures because of higher durability and improved bone integration performance.

By Application

ASCs: Ambulatory Surgical Centers (ASCs) accounted for approximately 21% of Knee Replacement market procedures during 2024. More than 820,000 outpatient knee replacement surgeries were performed globally within ASCs due to reduced hospitalization costs and faster patient discharge protocols. Outpatient procedures lowered overall treatment duration by nearly 48 hours compared with hospital-based surgeries. Minimally invasive surgical techniques represented 44% of ASC procedures because of reduced postoperative pain and faster rehabilitation. Robotic-assisted systems were integrated into 29% of advanced ASCs, improving implant placement accuracy significantly. Patients treated within ASCs reported 17% lower postoperative infection rates compared with traditional inpatient procedures. Medicare-supported outpatient surgeries increased by 14% during recent years, supporting ASC expansion.

Hospitals: Hospitals dominated the Knee Replacement market with nearly 79% procedure share during 2024 due to comprehensive orthopedic infrastructure and advanced postoperative care facilities. More than 3 million knee replacement procedures were conducted annually in hospitals worldwide. Robotic-assisted surgical systems were installed in 54% of major orthopedic hospitals, increasing surgical precision and reducing revision risks by 13%. Hospitals managed nearly 92% of revision surgeries due to higher procedural complexity and intensive care requirements. Cemented implants represented 72% of hospital procedures because of improved long-term stability. Orthopedic hospitals with specialized rehabilitation departments reduced patient recovery duration by 31%. Digital surgical navigation systems were integrated into 41% of hospitals globally during 2024.

Knee Replacement Market Regional Outlook

Download FREE Sample to learn more about this report.

North America

North America dominated the Knee Replacement market with approximately 42% global share during 2024. The United States alone performed nearly 1.2 million knee replacement procedures annually, while Canada contributed over 110,000 surgeries. Robotic-assisted knee replacement adoption reached 54% among orthopedic hospitals across the region. Obesity prevalence exceeding 40% among adults significantly increased osteoarthritis incidence and surgical demand. Patients aged above 65 years represented 66% of all knee replacement procedures.

Hospitals in North America integrated digital orthopedic navigation systems into 47% of operating rooms, improving implant positioning accuracy by 31%. Outpatient knee replacement surgeries accounted for 36% of total procedures due to enhanced rehabilitation protocols and minimally invasive surgical techniques. Cementless implants gained popularity among younger patients, accounting for 29% of procedures in patients below 60 years. Revision surgeries represented 11% of total procedures because of implant wear and infection-related complications. The region also recorded high adoption of customized implants, with 22% of surgeries utilizing patient-specific instrumentation. Smart implants equipped with sensor technologies accounted for 8% of advanced orthopedic procedures. Medicare-supported orthopedic treatments covered approximately 63% of surgeries in the United States. Orthopedic surgeon density remained among the highest globally at nearly 8 surgeons per 100,000 population, supporting high procedure volumes and reduced waiting times.

Europe

Europe accounted for approximately 29% of the global Knee Replacement market during 2024. Germany, the United Kingdom, France, and Italy represented nearly 68% of regional procedure volumes. Germany performed more than 230,000 knee replacement surgeries annually, while the United Kingdom recorded approximately 125,000 procedures. Public healthcare reimbursement systems supported nearly 74% of orthopedic procedures across Western Europe.

Robotic-assisted surgeries represented 18% of regional procedures, with adoption concentrated in Germany and France. Cemented implants maintained 76% penetration because of established clinical outcomes and surgeon familiarity. Patients aged above 65 years accounted for 71% of total procedures due to rising life expectancy reaching 81 years across the region. Hospitals implementing minimally invasive techniques reduced patient hospitalization periods to nearly 3 days. Partial knee replacement procedures represented 19% of regional surgeries due to increasing early-stage osteoarthritis diagnosis. Customized implant utilization reached 16% among advanced orthopedic centers. Revision procedures accounted for approximately 9% of surgeries, primarily related to implant wear and infection management. Digital rehabilitation platforms supporting postoperative recovery were integrated into 27% of orthopedic facilities, improving patient mobility outcomes and reducing readmission rates by 12%.

Asia-Pacific

Asia-Pacific represented approximately 21% of the global Knee Replacement market during 2024, supported by rising healthcare investments and expanding orthopedic infrastructure. China, Japan, India, South Korea, and Australia accounted for nearly 79% of regional procedures. Japan performed more than 190,000 knee replacement surgeries annually due to high elderly population ratios exceeding 29%. China recorded over 420,000 procedures during 2024 because of increasing orthopedic healthcare access.

Robotic-assisted surgical adoption reached 14% across the region, with South Korea and Japan leading technology integration. India experienced rapid orthopedic expansion, with knee replacement procedures increasing by 18% during recent years. Cemented implants accounted for 74% of surgeries because of affordability advantages. Hospitals represented 83% of total procedures due to limited outpatient orthopedic infrastructure.Medical tourism significantly influenced regional growth, particularly in India, Thailand, and Singapore, where orthopedic treatment costs remained 45% lower than North American averages. Minimally invasive procedures accounted for 31% of surgeries, improving recovery durations substantially. Customized implants represented 11% of procedures, particularly within urban healthcare centers. Orthopedic surgeon availability remained uneven, with rural regions reporting fewer than 1 specialist per 100,000 population.

Middle East & Africa

Middle East & Africa accounted for approximately 8% of the global Knee Replacement market during 2024. Saudi Arabia, South Africa, and the United Arab Emirates represented nearly 61% of regional procedure volumes. More than 180,000 knee replacement surgeries were performed annually across the region, supported by expanding healthcare infrastructure investments. Obesity prevalence exceeding 35% in Gulf countries significantly increased osteoarthritis-related procedure demand.

Hospitals dominated regional procedures with nearly 91% share due to limited ambulatory surgical infrastructure. Robotic-assisted surgeries represented 9% of procedures, concentrated primarily within private hospitals in the United Arab Emirates and Saudi Arabia. Cemented implants accounted for 79% of surgeries because of lower implant costs and established clinical reliability. Medical tourism contributed significantly to orthopedic procedure volumes in the UAE, where international patients represented 18% of surgeries. Government healthcare modernization initiatives increased orthopedic operating room capacity by 13% across major urban centers. Revision procedures represented 7% of surgeries due to lower historical implant penetration. Surgeon shortages remained a challenge, with some African countries reporting fewer than 0.5 orthopedic specialists per 100,000 population. Digital rehabilitation systems were integrated into 11% of advanced hospitals across the region.

List of Top Knee Replacement Companies

• Zimmer Biomet
• DePuy Synthes
• Stryker
• Smith & Nephew
• Exactech
• ConforMis
• Aesculap Implant Systems
• Arthrex
• Arthrosurface
• Baumer
• Braun
• Medacta
• MicroPort Scientific
• Corin Group
• Waldemar LINK
• DJO Global

List of Top Two Companies Market Share

• Zimmer Biomet held approximately 28% market share in global knee replacement implants during 2024, supported by robotic-assisted ROSA Knee System installations across more than 1,400 hospitals globally.
• Stryker accounted for nearly 22% market share due to strong Mako robotic-assisted surgery adoption and expanded orthopedic implant distribution across North America and Europe.

Investment Analysis and Opportunities

Investment activity within the Knee Replacement market increased significantly during 2024 due to rising demand for robotic-assisted orthopedic surgeries and personalized implants. Orthopedic robotic systems installations increased by 23% globally, with hospitals investing heavily in AI-assisted surgical technologies. More than 410 new orthopedic surgical centers were established across Asia-Pacific during the past two years. Governments in developed economies expanded orthopedic healthcare budgets by 11%, supporting modernization of surgical infrastructure.

Private equity investments in orthopedic technology startups increased by 17%, particularly in companies specializing in smart implants and digital rehabilitation systems. Customized implant production facilities expanded by 14% globally due to increasing demand for patient-specific solutions. Ambulatory surgical centers received major investments because outpatient procedures reduced operational costs by approximately 21%.

New Product Development

New product development within the Knee Replacement market is focused on robotic-assisted systems, personalized implants, and advanced biomaterials. During 2024, more than 27% of newly introduced implants incorporated enhanced polyethylene materials designed to reduce wear rates by 35%. Customized 3D-printed implants expanded significantly, particularly for revision procedures and patients with anatomical deformities.

Robotic-assisted surgical systems equipped with AI-based navigation software improved implant positioning accuracy by 32%. Smart implants capable of transmitting real-time movement and load data represented 9% of newly launched orthopedic technologies. Cementless implants designed for younger patients achieved fixation success rates exceeding 94% within advanced clinical trials. Manufacturers also introduced minimally invasive surgical instruments reducing tissue damage by nearly 28%. Mobile-bearing knee systems with enhanced rotational flexibility improved postoperative mobility outcomes by 19%. Digital rehabilitation platforms connected with wearable monitoring devices increased patient therapy compliance by 26%.

Five Recent Developments (2023-2025)

• In 2024, Zimmer Biomet expanded ROSA robotic knee system installations by 24%, exceeding deployment across 1,400 healthcare facilities globally.
• In 2023, Stryker enhanced its Mako robotic platform with AI-assisted alignment technology improving implant positioning precision by 32%.
• In 2024, Smith & Nephew introduced advanced cementless knee implants designed to improve bone integration efficiency by 29%.
• In 2025, Exactech launched next-generation polyethylene inserts reducing implant wear rates by nearly 35% during laboratory testing.
• In 2023, Medacta expanded personalized knee implant production capacity by 18% to support rising demand for patient-specific orthopedic procedures.

Report Coverage of Knee Replacement Market

The Knee Replacement market report provides comprehensive analysis covering implant types, applications, surgical technologies, regional performance, competitive landscape, and innovation trends. The report evaluates more than 16 major orthopedic manufacturers and analyzes procedure volumes across over 45 countries. Primary knee replacement procedures represented 74% of analyzed surgeries, while revision procedures accounted for 10% of total market evaluation.

The report includes detailed assessment of robotic-assisted surgery systems, which represented 19% of global procedures during 2024. Cemented implant penetration reached 72%, while cementless technologies accounted for 28% of procedures among younger patient populations. Hospitals maintained 79% market share, whereas ambulatory surgical centers contributed 21%. Regional analysis covers North America, Europe, Asia-Pacific, and Middle East & Africa with detailed insights regarding orthopedic infrastructure, surgeon availability, healthcare expenditure patterns, and patient demographics. The report also evaluates technological advancements such as AI-assisted surgical planning, digital rehabilitation systems, and smart implant monitoring technologies.